Rules › IRS-2023-0045

Excise Tax on Designated Drugs; Procedural Requirements

Proposed rule from the Treasury Department, Internal Revenue Service (docket IRS-2023-0045). 2 comment letters from companies and organizations are listed below.

Agency
Treasury Department, Internal Revenue Service
Docket
IRS-2023-0045
Published
2023-10-02
Comments due
2023-12-01
Status
Comment period closed December 1, 2023 · no final rule found yet
Total public comments
2
Letters listed here
2

Federal Register notice ↗ · Docket on Regulations.gov ↗

Who commented, by industry

Advocacy & Nonprofits 1 Pharma & Medical Devices 1

Who commented

Arnold Ventures, LLC Company Advocacy & Nonprofits

filed as “Arnold Ventures” · filed 2023-12-04

Pharmaceutical Research and Manufacturers of America (PhRMA) Trade or professional group Pharma & Medical Devices

filed as “PhRMA” · filed 2023-12-04